Drugs / BAT8003
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT03884517 | Mar 2019 → Feb 2021 | cancer | Bio-Thera Solutions | Terminated | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | BAT8003 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT03884517 ↗ |
| Route | Intravenous | “intravenous infusion” NCT03884517 ↗ |